ALAMEDA, Calif., Dec. 21, 2017 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 9, 2018.
|
Event: |
36th Annual J.P. Morgan Healthcare Conference |
|
Date: |
Tuesday, January 9, 2018 |
|
Time: |
4:30pm ET / 1:30pm PT |
A webcast of the presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on interventional therapies. Penumbra designs, develops, manufactures and markets innovative devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
SOURCE Penumbra, Inc.